Hep C Screening

Hepatitis C: Screening and Diagnosis

Focus on Hepatitis B and C risk based screening

Posted on April 18, 2015

Real-life clinical relevance of hepatitis screening in Germany: enhancing risk based screening strategies in primary care settings Effective screening programs are needed to identify HBsAg and anti-HCV positive patients. Population based anti-HCV screening of all adults born between 1945 and 1965 is recommended in the US. For hepatitis B, US-guidelines recommend screening of adults at high risk of infection such as immigrants from regions ...

Read More

Urgent need for birth cohort hepatitis C testing

Posted on April 13, 2015

Study highlights urgent need to implement recent CDC and USPTF birth cohort Hepatitis C testing recommendations in the routine clinical environment While there have been many recent notable advances in the treatment of hepatitis C, these advances can only help those individuals who are tested and identified. Unfortunately, the proportion of unidentified anti-HCV positive persons has been estimated as ranging from 40% to 85%, and it’s ...

Read More

Real-life HCV management in US urban center

Study provides a “real-life” snapshot of how HCV infection is being addressed in a major US urban center Acute hepatitis C infection is asymptomatic in 60-70% of individuals. Many people only learn that they are HCV-positive decades later, after their disease has progressed to cirrhosis, hepatocellular carcinoma, or liver failure. Unfortunately, 50-75% of people chronically infected with HCV remain unaware of their infection. Even if the ...

Read More

HCV linkage-to-care for baby boomers in the ED

Recent study highlights the necessity of providing HCV screening and linkage-to-care to baby boomer patients in the emergency department HCV-infected individuals are more likely to use the emergency department (ED) for care than any other healthcare venue. HCV antibody prevalence appears to be between 4-18% in the general ED population. Frequent users of the care provided by EDs including minorities, Medicaid recipients, and uninsured/under...

Read More

Viral load quantification: Hepatitis therapy barrier

Posted on April 6, 2015

Hepatitis viral load quantification is lacking in low- and middle-income countries, and this is a major barrier to the provision of therapies to patients who need them Viral load quantification is considered a mandatory component of the diagnostic work-up in all international liver society guidelines. Low- and middle-income countries typically lack access to viral load quantification, and this has become a major barrier to the provision of ...

Read More

Rapid HCV testing in jails: linkage to care barrier

Posted on April 1, 2015

Rapid HCV testing within jails identifies previously unrecognized cases of HCV infection, but linkage to care after release is a major barrier One-third of all HCV-infected individuals in the USA pass through the criminal justice system each year, so at any given time the correctional population in the USA bears a heavy burden of HCV infection. HCV antibody prevalence among incarcerated adults in North America is estimated to be 29%, and the ...

Read More

Barriers to Hepatitis C Screening and Testing

Posted on March 31, 2015

US Healthcare Providers Share Perspectives on Barriers to Hepatitis C Screening and Testing In 2012, the Centers for Disease Control and Prevention (CDC) recommended that all individuals born during 1945 to 1965 (the birth cohort with the highest prevalence of HCV) receive a onetime test for HCV, assessment for alcohol use and intervention as indicated, and linkage to care and treatment as appropriate. CDC’s 2012 recommendations supplement ...

Read More

PCPs report lack of confidence in HCV screening

60% of primary care physicians report a lack of confidence in screening for hepatitis C A survey of Primary Care Physicians (PCPs) actively involved in the care of patients with Hepatitis C (HCV) reveals that up to 60% of PCPs are either not very confident or only somewhat confident about screening individuals for chronic HCV infection. This survey, highlighted by Dr. Edward Lebovics in his article published in the November 2014 issue of The ...

Read More

Hepatitis C is a Global Public Health Issue

Posted on February 23, 2015
Hepatitis C virus

Undiagnosed and Untreated Hepatitis C is a Global Public Health Issue Undiagnosed and untreated hepatitis C is a global public health issue, with growing numbers of patients suffering and dying from the consequences of chronic infection, including cirrhosis and hepatocellular carcinoma. HCV infection is typically asymptomatic until significant liver disease occurs, so a primary care provider would have few reasons to order diagnostic tests on ...

Read More